Our News
NOVEMBER 20, 2024
VRise Therapeutics Inc. Announces Acceptance of Late Breaking Abstract for San Antonio Breast Cancer Symposium®
OCTOBER 15, 2024
VRise Therapeutics Inc. Announces Acceptance of Late Breaking Abstract at 36th EORTC-NCI-AACR for USP1 Inhibitor VRTX531
OCTOBER 03, 2024
VRise Therapeutics Inc. Appoints Dr. Francesco Bertoni, an Expert Hemato-Oncologist
JUNE 30, 2023
VRise makes key translational research appointment in SAB with Dr. Colin Weekes
AUGUST 1, 2022
Distinguished Oncologist Dr. Junji Furuse To Join VRise Therapeutics Scientific Advisory Board
JULY 21, 2022
VRise Therapeutics Inc. Announces Expansion Of Its Scientific Advisory Board
JULY 11, 2022
VRise Therapeutics Announces Eminent Oncologist Dr. Anthony W. Tolcher Joining Its Scientific Advisory Board
JULY 04, 2022
VRise Therapeutics Announces Joining Of Dr. Darren Tyson, Vanderbilt University, To Its Scientific Advisory Board
MARCH 02, 2022
VRise Therapeutics, Inc. Announces Scientific Presentations At The Upcoming AACR Annual Meeting, 2022